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Abstract
AIM: To evaluate the clinical and endoscopic patterns in 
a large series of patients with metastatic tumors in the 
stomach.
METHODS: A tota l o f 64 pat ients wi th gast r i c 
metastases from solid malignant tumors were retros-
pectively examined between 1990 and 2005. The 
clinicopathological findings were reviewed along with 
tumor characteristics such as endoscopic pattern, 
locations, size and origin of the primary sites. 
RESULTS: Common indications for endoscopy were 
anemia, bleeding and epigastric pain. Metastases 
presented as solitary (62.5%) or multiple (37.5%) and 
were mainly located in the middle or upper third of 
stomach. The main primary metastatic tumors were from 
breast and lung cancer and malignant melanoma. 
CONCLUSION: As the prognosis of cancer patients 
has been improving gradually, gastrointestinal (GI) 
metastases will be encountered more often. Endoscopic 
examinations should be conducted carefully in patients 
with malignancies, and endoscopic biopsies and 
information on the patient’s clinical history are useful for 
correct diagnosis of gastric metastases.
© 2006 The WJG Press. All rights reserved.
Key words: Stomach; Metastatic tumors; Clinical fi ndings; 
Pathology; Endoscopy
De Palma GD, Masone S, Rega M, Simeoli I, Donisi M, Ad-
deo P, Iannone L, Pilone V, Persico G. Metastatic tumors to 
the stomach: Clinical and endoscopic features. World J Gas-
troenterol  2006; 12(45): 7326-7328
 http://www.wjgnet.com/1007-9327/12/7326.asp
INTRODUCTION
The stomach is an unusual site for metastasis. There have 
been several published reports on metastatic lesions in 
the stomach. However, information on gastric duodenal 
metastases is generally limited to single case reports. The 
present study examined the clinopathological features in 
a large series of  patients with metastatic tumors in the 
stomach from distant sites.
MATERIALS AND METHODS
We conducted a chart review of  patients with metastatic 
tumors of  the stomach detected endoscopically from 
January 1990 to December 2003. Patients with malignant 
lymphoma involving the stomach, or with direct invasion 
from neighboring organs, were excluded from this study. 
Analysis of  data included indication for endoscopy, 
endoscopic appearance, location, primary site and time 
interval between the diagnosis of  primary tumors and 
diagnosis of  metastatic lesions. 
RESULTS
The present study included 64 patients, 36 men and 
28 women, with a mean age of  56 years (28-82 years). 
The common indications for endoscopy were anemia 
or bleeding (19 cases, 10 of  which had active bleeding), 
dyspepsia (15 cases) and epigastric pain (14 cases). 
Endoscopic fi ndings mainly included small nodules with 
or without central ulceration, polypoid mass and ulcers. 
The other findings included peptic ulcer scar and small 
black spots, which were metastatic tumors from malignant 
melanoma. Solitary metastases (40 cases, 62.5%) were 
more common than multiple metastases (24 cases, 37.5%). 
The solitary lesions were mainly located in the middle 
third (43%) or the upper third (45%) of  the stomach, and 
the proportion of  solitary lesions was similar to that of  
multiple lesions. Forty percent of  the solitary lesions and 
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35% of  the multiple lesions were located on the greater 
curvature (Table 1).
The diagnosis of  metastatic tumors was confirmed 
pathologically by endoscopic biopsies in 59 out of  64 cases 
(92.2%). The remaining 5 cases were diagnosed during 
surgery for uncontrollable bleeding from the tumor. The 
primary sites of  metastases are shown in Table 2.
The average time interval between the diagnosis of  
primary tumors and the diagnosis of  metastatic lesions was 
25.7 mo (1-40 mo), and varied the site of  primary tumor 
(Table 3).
DISCUSSION 
The stomach is an unusual site for metastasis[1-8]. As the 
prognosis of  cancer patients has been improving gradually, 
gastric metastases are encountered more frequently. In 
this series, lung, breast, and esophagus were the common 
primary metastatic sites, and malignant melanoma was 
associated with the highest rate of  metastases. More than 
half  of  the metastatic tumors were found within a year of  
the diagnosis of  a primary tumor. In particular, most of  
the gastric metastases from esophageal and lung cancer 
were detected within a year, since these cancers progress 
rapidly. On the other hand, breast cancer extended slowly, 
and it was sometimes more than three years before gastric 
metastases were diagnosed after the initial diagnosis of  the 
primary tumor. It was noteworthy that metastatic tumors 
were detected before diagnosis of  the primary tumors in 2 
patients[8,9]. Symptoms of  metastatic tumors including pain, 
nausea, vomiting, and signs of  bleeding are nonspecifi c[4-9]. 
Endoscopy may be useful in the diagnosis and local 
treatment of  gastric metastases, such us endotherapy that 
was performed successfully in 5 out of  10 patients with 
active gastrointestinal (GI) bleeding (endoscopic clipping 
in 4 cases and adrenaline injection in 1 case). In our series, 
more frequent endoscopic patterns included multiple 
nodules, bull’s eye, extrinsic mass lesions, ulceration and 
polypoid tumor mass as previously reported[4-8,10-13].
Solitary metastases were more common than multiple 
metastases. The solitary lesions were mainly located in 
the middle third (40%) or the upper third (40%) of  the 
stomach, and the proportion of  the solitary lesions was 
similar to that of  the multiple lesions. Forty percent of  
the solitary lesions and 35% of  the multiple lesions were 
located on the greater curvature. About 90% of  the 
metastatic lesions could be confirmed histologically by 
endoscopic biopsies. Tumor-negative biopsies may be 
mainly due to extrinsic mass rather than due to sampling 
error. It should be emphasized that the endoscopist should 
provide the pathologist with suffi cient information about 
the patient’s history to allow an accurate pathological 
diagnosis.
In conclusion, as the prognosis of  cancer patients 
has been improving gradually, GI metastases will be 
encountered more often.  Endoscopic examinations should 
be conducted carefully in patients with malignancies, and 
endoscopic biopsies and information on the patient’s 
clinical history is useful for the correct diagnosis of  gastric 
metastasis.
Table 1  Endoscopic appearance and location of metastatic 
lesions, n  (%)
Small nodules 28 (43.7)
Polypoid mass 18 (28.1)
Ulcers   8 (12.5)
Small black spots   6 (9.3)
Peptic ulcer scar   4 (6.2)
Lower third   8 (12.5)
Middle third 27 (42.2)
Upper third 29 (45.3)
Solitary 40 (62.5)
Multiple 24 (37.5)      
Table 2  Site of primary tumor, n  (%)
Breast 21 (32.8)
Lung 16 (25.0)
Malignant melanoma 14 (21.9)
Head/Neck   4 (6.2)
Uterus   4 (6.2)
Colorectum   3 (4.7)
Kidney   2 (3.1)
Soft Tissue   1 (1.5)
Table 3  Time interval between the diagnosis of primary tumors 
and diagnosis of metastatic lesions
Time (yr)    Patients               Primary Site
      n  (%)           Lung         Breast        Melanoma  Other
-1   2 (3.1)   1   1
1-2 33 (51.5) 11   9   7                     6
2-3 19 (29.6)   3   8   4   4
> 3 10 (15.6)   1   4   3   2
Total 64 (100) 16 21 14 13
COMMENT 
1. Backgrounds
The stomach is an unusual site for metastasis. There 
have been several published reports on metastatic lesion 
in the stomach and information on gastric duodenal 
metastases is generally limited to single case reports. 
The present study examined the endoscopic and 
clinopathological features in a large series of  patients 
with metastatic tumors to the stomach.
2. Research frontiers
As the prognosis for cancer patients has been improving 
gradually, GI metastases will be encountered more often.  
3. Innovations and breakthroughs
Metastasis to stomach is rare, hence no large series has 
been published so far. The current study is an improve-
ment in terms of  numbers of  cases. It reemphasises the 
same results which have been published earlier.
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4. Applications 
Endoscopic examinations should be conducted carefully 
in patients with malignancies, and endoscopic biopsies 
and information on the patient’s clinical history is useful 
for correct diagnosis of  gastric metastasis.
5. Terminology
Metastatic tumors to the stomach.
6. Peer review
The current paper gives retrospective analysis of  data on 
Metastatic tumors to stomach over a period of  15 years 
at author’s center. Metastasis to stomach is rare, hence 
no large series has been published so far. Oda et all have 
published a series of  54 cases of  metastatic tumors to 
stomach in 2001. The current study is slight improvement 
in terms of  numbers of  cases. Authors have reported in 
the current article that 19 cases underwent endoscopy due 
to bleeding and 5 cases were diagnosed with metastatic 
tumors at time of  surgery due to uncontrolled bleeding.
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